A balanced view of choroid plexus structure and function: Focus on adult humans.
Recently tremendous progress has been made in studying choroid plexus (CP) physiology and pathophysiology; and correcting several misconceptions about the CP. Specifically, the details of how CP, a locus of the blood-CSF barrier (BCSFB), secretes and purifies CSF, generates intracranial pressure (ICP), maintains CSF ion homeostasis, and provides micronutrients, proteins and hormones for neuronal and glial development, maintenance and function, are being understood on a molecular level. Unequivocal evidence that the CP secretory epithelium is the predominant supplier of CSF for the ventricles comes from multiple lines: uptake kinetics of tracer (22)Na and (36)Cl penetration from blood to CSF, autoradiographic mapping of rapid (22)Na and (36)Cl permeation (high permeability coefficients) into the cerebroventricles, CSF sampling from several different in vivo and in vitro CP preparations, CP hyperplasia that increases CSF formation and ICP; and in vitro analysis of CP ability to transport molecules (with expected directionality) and actively secrete fluid against an hydrostatic fluid column. Furthermore, clinical support for this CP-CSF model comes from neurosurgical procedures to remove lateral ventricle CPs in hydrocephalic children to reduce CSF formation, thereby relieving elevated ICP. In terms of micronutrient transport, ascorbic acid, folate and other essential factors are transported by specific (cloned) carriers across CP into ventricular CSF, from which they penetrate across the ependyma and pia mater deeply into the brain to support its viability and function. Without these choroidal functions, severe neurological disease and even death can occur. In terms of efflux or clearance transport, the active carriers (many of which have been cloned and expressed) in the CP basolateral and apical membranes perform regulatory removal of some metabolites (e.g. choline) and certain drugs (e.g. antibiotics like penicillin) from CSF, thus reducing agents such as penicillin to sub-therapeutic levels. Altogether, these multiple transport and secretory functions in CP support CSF homeostasis and fluid dynamics essential for brain function.
Department of Medicine, Robert Wood Johnson Medical School, Piscataway, NJ 08554, USA. Electronic address: mspec007@gmail.com.
Reynold
R
Spector
Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48105, USA. Electronic address: rkeep@med.umich.edu.
Richard F
RF
Keep
Departments of Neurology and Pediatrics, Harbor-UCLA Medical Center, David Geffen UCLA School of Medicine, Torrance, CA 90502, USA. Electronic address: bobsnodgrass@mac.com.
S
S
Robert Snodgrass
Department of Pharmaceutical Sciences, School of Pharmacy, Amarillo, TX 79106, USA. Electronic address: Quentin.Smith@ttuhsc.edu.
Quentin R
QR
Smith
Department of Neurosurgery, Alpert Medical School at Brown University, Providence, RI 02903, USA. Electronic address: Conrad_Johanson@Brown.edu.
Conrad E
CE
Johanson
D000328:Adult; D001812:Blood-Brain Barrier / Q000502:physiology*; D002555:Cerebrospinal Fluid / Q000502:physiology*; D002831:Choroid Plexus / Q000033:anatomy & histology* / Q000502:physiology*; D006801:Humans; D007427:Intracranial Pressure / Q000502:physiology*
Acetazolamide inhibition; Blood–CSF barrier; CSF circulation; CSF pharmacokinetics; Cerebrospinal fluid; Cerebroventricular micronutrients; Choroid plexectomy; Intracranial pressure; Reabsorptive transport; Water movement